Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Healthcare
Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Quipt Home Medical Corp > Assessment
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(972)
•••
Comment by Moemoney42on Jan 24, 2021 1:53pm
729 Views
Post# 32371177

RE:RE:RE:Assessment

RE:RE:RE:AssessmentWow.. thats some pretty large EPS swings..! RJ, Stifel & Cannacord sure need to look a little closer at their calculations IMHO.. maybe they're talking their book.. hoping to fool some retails into selling cheap before they get exposed for their lack of understanding/knowledge... :-/
lscfa wrote:

 

 

2021

2022

Beacon

$0.10

 

Echelon

$0.06

 

Raymond James

($0.01)

$0.04

Canaccord

$0.02

 

Dougherty

$0.08

 

Leede Jones

$0.10

$0.20

Colliers

$0.10

 

Stifel 

($0.01)

$0.13

IA Securities

$0.09

$0.22

M Partners

$0.05

 

Avg =

$0.058

$0.148

 



 

lscfa wrote: 5i is out to lunch.    Consensus eps for 2021 is $0.06 so $2.07 Sh pr. = 34x but ebitda is what all the analysts base valuation on.    
 

 

retiredcf wrote: PTQ has shown good improvement in cash flows and margins over the years and it continues to look interesting. However a lot of growth is expected and shares are more expensive today at 72x forward earnings, so there is some risk here. It is also a smaller company (than VMD) at just under $300M so we would exert caution with position sizing. We think a Nasdaq listing would bode well for the company. Getting listed in the US can certainly help with momentum of shares in the short term and long-term liquidity for both companies.

So said 5iResearch last Wednesday. GLTA

 




<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities